Sisu Pharma Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Sisu Pharma is a biotechnology research company based in San Diego, California. It targets HSF1, the master regulator of the heat shock response, to develop approaches that degrade this protein. Its HI-LiTe platform is being developed to deliver selective HSF1 degraders for oncology and for therapies in neurodegenerative diseases and infections. The company has a small team based in the San Diego region. In April 2023, Professor Michael Jung joined its Scientific Advisory Board. The company maintains a website at sisupharma.com.